Page last updated: 2024-10-29

iproniazid and Libman-Sacks Disease

iproniazid has been researched along with Libman-Sacks Disease in 1 studies

Research Excerpts

ExcerptRelevanceReference
"The syndrome resembling systemic lupus erythematosus (SLE) associated with long-term treatment with hydralazine and isoniazid seems to be due to the drugs themselves rather than their metabolites."1.27Drugs that induce systemic lupus erythematosus inhibit complement component C4. ( Gill, EW; Sim, E; Sim, RB, 1984)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sim, E1
Gill, EW1
Sim, RB1

Other Studies

1 other study available for iproniazid and Libman-Sacks Disease

ArticleYear
Drugs that induce systemic lupus erythematosus inhibit complement component C4.
    Lancet (London, England), 1984, Aug-25, Volume: 2, Issue:8400

    Topics: Acetylation; Complement C4; Complement Pathway, Classical; Humans; Hydralazine; Iproniazid; Isoniazi

1984